4.7 Article

Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON)

期刊

JOURNAL OF MAGNETIC RESONANCE IMAGING
卷 27, 期 5, 页码 1175-1180

出版社

JOHN WILEY & SONS INC
DOI: 10.1002/jmri.21337

关键词

inversion recovery with ON-resonant water suppression (IRON); off-resonance imaging; monocrystalline iron oxide nanoparticle (MION-47); magnetic resonance lymphography

资金

  1. NCI NIH HHS [R24 CA092782-05, P50 CA086355, R24 CA092782, P50CA86355, R24CA92782, P50 CA086355-01] Funding Source: Medline
  2. NHLBI NIH HHS [R01 HL073223-04, R01 HL084186, R01 HL073223] Funding Source: Medline
  3. NIBIB NIH HHS [1 K08 EB004922-01, K08 EB004922] Funding Source: Medline

向作者/读者索取更多资源

Purpose: To investigate the utility of inversion recovery with ON-resonant water suppression (IRON) to create positive signal in normal lymph nodes after injection of superparamagnetic nanoparticles. Materials and Methods: Experiments were conducted on six rabbits, which received a single bolus injection of 80 p,mol Fe/kg monocrystalline iron oxide nanoparticle (MION-47). Magnetic resonance imaging (MRI) was performed at baseline, I day, and 3 days after MION-47 injection using conventional T-1- and T-2*-weighted sequences and IRON. Contrast-to-noise ratios (CNR) were measured in blood and in paraaortic lymph nodes. Results: On T-2*-weighted images, as expected, signal attenuation was observed in areas of paraaortic lymph nodes after MION-47 injection. However, using IRON the paraaortic lymph nodes exhibited very high contrast enhancement, which remained 3 days after injection. CNR with IRON was 2.2 +/- 0.8 at baseline, increased markedly 1 day after injection (23.5 +/- 5.4, P < 0.01 vs. baseline), and remained high after 3 days (21.8 +/- 5.7, *P < 0.01 vs. baseline). CNR was also high in blood I day after injection (42.7 +/- 7.2 vs. 1.8 +/- 0.7 at baseline, P < 0.01) but approached baseline after 3 days (1.9 +/- 1.4, P = NS vs. baseline). Conclusion: IRON in conjunction with superparamagnetic nanoparticles can be used to perform 'positive contrast' MR-lymphography, particularly 3 days after injection of the contrast agent, when signal is no longer visible within blood vessels. The proposed method may have potential as an adjunct for nodal staging in cancer screening.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据